In order to identify immunogenic VV genes that can be used for tumor gene therapy, we immunized mice using VV and then stimulated splenocytes from these mice ex vivo with previously reported immunogenic peptides derived from K3L, B2R, B8R, A8R, and A3L of VV.25 Here, BDKRB2 is linked to neoplasm.